Cognizant CTSH Delivers Q1 2026 Beat EPS 140 vs 136 Expected Nordson Corporation NDSN Gains 068 Support Holds at 26292 20260518 Cerus CERS Q1 2026 Beat Revenue NA EPS Exceeds by Significant China Signals Openness to Deal Keeping TikTok in the US Report ProCap Financial Warrants Surge 10 Technical Bottoms and Resistance Challenges Rupee Tumbles to AllTime Low as Dollar Demand Crude Rally Intensify Pressure US Consumer Sentiment Remains Subdued Amid Inflation Geopolitical Conflicts and Trade Policy Uncertainty Eco Wave WAVE Q1 2026 Earnings Beat Revenue NA EPS 008 AI Economy Reshapes Labor Demand ATT CEO Highlights BlueCollar Worker Shortage Japan Core Inflation Eases to Over FourYear Low Dimming Prospects for BOJ Rate Hike South Korea Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Disputes US April Payrolls Surge Past Expectations Yet Report Highlights Economic Warning Signs US Fuel Prices Unlikely to Normalize This Year Even if Iran Conflict Ends Analysts Suggest Comparing HighProfile Visits to China Could Macrons Approach Have Yielded More Than Trumps TrustCo Bank Corp NY Q1 2026 Earnings Steady EPS Amid Quiet Quarter Supernus Pharmaceuticals SUPN Q1 2026 Earnings EPS Surges Past Expectations but Stock Retreats 5E Advanced Materials Inc FEAM Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Phase Continues FRME Q1 2026 Earnings Strong EPS Beat Amid Modest Stock Decline SAM Q1 2026 Earnings EPS Misses Estimates Amidst Persistent Cost Headwinds Stephen Mirans Fed Exit Laying the Groundwork for Kevin Warshs Potential Chairmanship AMETEK AME Climbs 155 Resistance at 23595 in Focus 20260520 Accenture Doubles Down on Gen Z Consulting Giant Expands EntryLevel Hiring as Peers Pull Back Nvidia Surpasses Quarterly Projections as AI Chip Demand Fuels Record Revenue Midcap and Smallcap Stocks Surge Up to 112 YTD in 2026 Analysts Weigh Sustainability Fed Dissenters Explain No Votes Over Rate Cut Forward Guidance Standard Chartered to Cut Over 15 of Corporate Functions Roles in Efficiency Drive Xenetic Biosciences Q2 2025 Earnings Narrowed Loss Beats Estimates as Pipeline Advances